Articles

1. Non-serious case reports

   News item 11 May 2024 Pages: 334 - 334

2. Warfarin

   Case report 11 May 2024 Pages: 333 - 333

3. Warfarin

   Case report 11 May 2024 Pages: 332 - 332

4. Vitamin-D

   Case report 11 May 2024 Pages: 331 - 331

5. Vedolizumab

   Case report 11 May 2024 Pages: 330 - 330

6. Vancomycin

   Case report 11 May 2024 Pages: 329 - 329

7. Valproic-acid

   Case report 11 May 2024 Pages: 328 - 328

8. Valganciclovir

   Case report 11 May 2024 Pages: 327 - 327

9. Ursodeoxycholic-acid

   Case report 11 May 2024 Pages: 326 - 326

10. Upadacitinib

    Case report 11 May 2024 Pages: 325 - 325

11. Tozinameran

    Case report 11 May 2024 Pages: 324 - 324

12. Tozinameran

    Case report 11 May 2024 Pages: 323 - 323

13. Tozinameran

    Case report 11 May 2024 Pages: 322 - 322

14. Tofacitinib

    Case report 11 May 2024 Pages: 321 - 321

15. Tocilizumab

    Case report 11 May 2024 Pages: 320 - 320

16. Tocilizumab

    Case report 11 May 2024 Pages: 319 - 319

17. Tislelizumab

    Case report 11 May 2024 Pages: 318 - 318

18. Tenofovir-disoproxil-fumarate

    Case report 11 May 2024 Pages: 317 - 317

19. Tafamidis-meglumine

    Case report 11 May 2024 Pages: 316 - 316

20. Tacrolimus

    Case report 11 May 2024 Pages: 315 - 315

21. Tacrolimus

    Case report 11 May 2024 Pages: 314 - 314

22. Sotrovimab

    Case report 11 May 2024 Pages: 313 - 314

23. Sorafenib

    Case report 11 May 2024 Pages: 312 - 312

24. Somatropin

    Case report 11 May 2024 Pages: 311 - 311

25. Sodium/tolvaptan

    Case report 11 May 2024 Pages: 310 - 310

26. Sintilimab

    Case report 11 May 2024 Pages: 309 - 309

27. Sildenafil

    Case report 11 May 2024 Pages: 308 - 308

28. Semaglutide

    Case report 11 May 2024 Pages: 307 - 307

29. Secukinumab

    Case report 11 May 2024 Pages: 306 - 306

30. Secukinumab

    Case report 11 May 2024 Pages: 305 - 305

31. Secukinumab

    Case report 11 May 2024 Pages: 304 - 304

32. Rivoceranib

    Case report 11 May 2024 Pages: 303 - 303

33. Rivaroxaban

    Case report 11 May 2024 Pages: 302 - 302

34. Rivaroxaban

    Case report 11 May 2024 Pages: 301 - 301

35. Rituximab/tocilizumab

    Case report 11 May 2024 Pages: 300 - 300

36. Rituximab

    Case report 11 May 2024 Pages: 299 - 299

37. Remifentanil

    Case report 11 May 2024 Pages: 298 - 298

38. Ranibizumab

    Case report 11 May 2024 Pages: 297 - 297

39. Rabeprazole/rebamipide

    Case report 11 May 2024 Pages: 296 - 296

40. Progesterone

    Case report 11 May 2024 Pages: 295 - 295

41. Prednisolone

    Case report 11 May 2024 Pages: 294 - 294

42. Piperacillin/tazobactam/vancomycin

    Case report 11 May 2024 Pages: 293 - 293

43. Pembrolizumab

    Case report 11 May 2024 Pages: 292 - 292

44. Pembrolizumab

    Case report 11 May 2024 Pages: 291 - 291

45. Pembrolizumab

    Case report 11 May 2024 Pages: 290 - 290

46. Pembrolizumab

    Case report 11 May 2024 Pages: 289 - 289

47. Pembrolizumab

    Case report 11 May 2024 Pages: 288 - 288

48. Pantoprazole

    Case report 11 May 2024 Pages: 287 - 287

49. Panitumumab

    Case report 11 May 2024 Pages: 286 - 286

50. Panitumumab

    Case report 11 May 2024 Pages: 285 - 285